International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer

Summary

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the compassionate use program.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications